More to science: working as a Science Policy Analyst

This piece was originally published on the BioMed Central blog network, part of Springer Nature.

There is more to science than being a scientist! As part of our ‘Science > Careers’ series, Dana Berry asks Chris Pickett from The American Society for Biochemistry and Molecular Biology more about his role as a Science Policy Analyst.

Chris Pickett is a Policy Analyst at the American Society for Biochemistry and Molecular Biology in Maryland, USA. You can read more from Chris on the ASBMB Policy Blotter, or follow him on Twitter.

How did you get interested in science?

I always had an interest in science, but my passion for it grew through high school. I enjoyed biology and physics and started studying both as an undergraduate. About a year in, I realized physics wasn’t for me, and I was also losing interest in biology. After a particularly difficult semester, I seriously considered dropping biology altogether.

However, I had already enrolled in Molecular Biology for the spring semester, and I decided I would make my decision about my major during the summer. About two weeks into the class, I was hooked again. For good this time. This class reignited my passion for biology, and it was in this semester that I decided to go to graduate school.

What is your scientific background?

I earned my BA in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder. For two years during my studies, I worked in a lab helping them with their contributions to the Human Genome Project.

I moved on to the University of Utah for graduate school. My thesis work characterized orthologs of putative oncogenic transcription factors in the nematode, Caenorhabiditis elegans. I then worked as a postdoc at Washington University in St. Louis for five years. Here I used C. elegans again to study the intersection of aging and reproduction.

Toward the end of my graduate studies and then through my postdoc, I became increasingly fascinated by the role federal policy plays in the functioning of the scientific enterprise. Specifically, I was interested in policies that affected the training of graduate students and postdocs.

Once I realized I was more interested in policy rather than academic jobs, I began applying for science policy fellowships. The American Society for Biochemistry and Molecular Biology offered me its fellowship in 2012 and I’ve been here ever since.

How do you spend your day in your job?

ChrisPickett

Congress and federal agencies appear to move quite slowly, but science policy is a pretty fast-paced field. Because of this I’ve found it difficult to describe a standard day. However, my days are often characterized by four different activities:

Research: Keeping up to date on current events and the actions of Congress and the administration is essential to a job in policy. It also means taking closer looks at policies or legislation that the society is interested in so that we can determine our best course of action.

Meetings: We meet regularly with members of Congress and their staff, staff at the NIH, the NSF and other science-related federal agencies, and representatives of other scientific societies. These meetings can be 30-minutes long, or they can take an entire day.

Organization: Keeping all of my projects on schedule can require a fair amount of organization. Furthermore, large events, like coordinating the ASBMB Student/Postdoc Hill Day, takes a lot of preparation and organization.

Writing: I would say 85% of my time is spent writing, and it’s all kinds of policy writing. Position statements, white papers, news releases, blog posts and even emails. Clear written communication is vital to a career in science policy.

Each day brings a different mix of these four tasks. Some days I’m on Capitol Hill all day, whereas others I’m writing one specific document because of a time crunch. And then some days see a healthy mix of all four.

What makes this a science job and what do you like most about it?

Many of the skills needed for science policy do not differ so much from the skills gained working at the bench. First, you need to think critically, and be able to discern changes to the forest and the trees. Policy and politics have many moving parts, and you need to understand how your group’s position or policy will affect other parts of the research enterprise.

Second, you need to pay attention. While at the bench, you read scientific publications. In policy, you read the news and policy-specific publications. Understanding what is going on in the larger government is essential.

However, some skills need to be learned on the job. I had limited policy-writing experience before landing my fellowship. But once I arrived, I was writing many different pieces, sometimes in the same day, for a variety of audiences. This is actually what I like most about the job.

News releases have a different audience than blog pieces, for example. Being able to switch communication styles depending on the audience takes quite a bit of practice. Similarly, understanding how each federal agency works with one another and how they work with Congress is something that is best learned while doing the job of policy.

What advice would you give your younger self?

It’s a romantic notion that putting all of your effort into a single career path, like becoming academic faculty, will result in success. So many things, foreseen and unforeseen, can alter your path and planning for only one outcome is foolish.

To put it another way, do you focus all of your time on a single line of experiments, or do you mitigate the risk of failure and work on multiple lines of experiments?

I would tell myself to sit down and figure out Career Plan A. And once that was mapped out, to figure out what Career Plans B, C and D were. Then I’d tell myself to put the majority of my effort into Plan A, and recognize just how much of that work is also relevant for following Plans B, C and D.

Furthermore, should the opportunity arise to participate in something that improves your resume for one of your possible career paths, take it. If Plan A works out, you will be able to contribute much more to your organization due to your broad experiences and training.

Should the time come to bail on Plan A, you will already have a body of work for your other career paths, and it will be straightforward to gauge what you need to do to follow one of these paths.

danaberry

Dana Berry graduated with a MS in Microbiology from New York University before joining BMC in 2014, where she manages the infectious diseases portfolio.

 

Suggested posts

Finding job satisfaction as a policy analyst

Q&A with Gerjon Ikink: Using policy to change science

Science careers are careers that involve science

 

March for Science 2018 gears up

Organisers of the second annual March for Science , scheduled for 14 April in Washington DC, are hoping to recapture the energy and enthusiasm that prompted more than 1 million researchers and others to march together last year across 600 cities around the world in support of evidence-based policy and upholding science for the greater good.

MarchforScience-Judith-2-smaller

Caroline Weinberg, an organizer for the upcoming march in Washington DC, expects smaller crowds than last year, although she admits her prediction may again be off the mark. “Last we expected 40,000 people, and we got around 100,000,” she says. She adds that most of the marchers in the nation’s capital city were concerned citizens, not practicing researchers.

In Washington DC and elsewhere, organisers envision events with fewer marchers, placards and chants but more advocacy-related activities. Weinberg and others aim to offer hands-on projects for those taking to the streets in Washington DC. In Berlin, Germany, organisers are planning a “local hero” programme where scientists will give public talks at bars, cafes and other venues. March-related activities in Portland, Oregon, will include speeches by local politicians and a science expo with at least 30 presenters, including a juggler who demonstrates the principles of physics.

The election and inauguration of Donald Trump for US president helped to spur marchers last year, and Weinberg says that she suspects that some scientists this year may be motivated to speak out against Trump’s recent budget proposal, which called for drastic cuts to the US Centers for Disease Control and Prevention spending plan . But she adds that the march and other forms of science activism shouldn’t depend on crises to draw interest and participation. “Our challenge is to build up a huge crowd and send a message that galvanizes everyone but to also make it sustainable,” she says. “We can’t allow our advocacy to be tethered to those moments.”

Roughly 15,000 people attended last year’s march in Portland, but that kind of enthusiasm will be hard to replicate, says Denesa Oberbeck, a behavioral neuroscientist at the Oregon Health & Science University in Portland and a member of the steering committee for this year’s march. “There’s some fatigue and some burnout, but we need to keep fighting,” she says. “We have to maintain an activist stance.”

Kristine Wadosky, a cancer researcher at Roswell Park Cancer Institute in Buffalo, New York, marched in Washington DC last year carrying a sign that read “Curing cancer is non-partisan.”  This year, she plans to join the march in Chicago, Illinois, where she will give a talk on advanced prostate cancer for the annual meeting of the American Association for Cancer Research. She says that she’s just as energized about science advocacy as ever before, and she thinks that many other young scientists feel the same way.

This time, Wadosky says, she won’t need a sign to send her message, which isn’t especially complicated. “I just want to go to show that I’m a scientists, and I exist,” she says.

 

Chris Woolston is a freelance writer in Billings, Montana.

 

Suggested reading:

Growing pains
In support of the March
Reflections on a movement

Finding job satisfaction as a policy analyst

Working in science policy is all about taking complex science from experts and translating it into something accessible, to be used in key decision making.

catherine-ball-naturejobs-blog-small

{credit}Image credit: Catherine Ball{/credit}

After completing a PhD at the University of Oxford, trying to find different ways to make biological tools for drug development, Catherine Ball moved into science policy, and in May 2015 she started her current role as Policy Analyst for the House of Lords Science and Technology Select Committee. Here she describes her transition from academia.

Click here to read about how Ball pursued science policy as a career.

Why did you decide to leave academia?

About two thirds of the way through my PhD I realised that academia wasn’t for me. I found it quite frustrating when things didn’t work in the lab and I struggled to cope with the fact that you could spend a whole day in the lab and be no further forward than you were when you started.

My area of research was also quite niche and theoretical, and sometimes it felt like research for research sake. I soon realised I was more interested in the broader context and implications of science. So, in 2013 I took up a role as Policy Advisor for the Biochemical Society and Society of Biology where I focused on antimicrobial resistance, equality & diversity, science policy in the devolved nations, open access and drug discovery.

What was the transition from academia to science policy like?

It was a big learning curve. It’s also about understanding the landscape, how policies are made, where scientific expertise feeds it and the best way for it to do so. I had little experience in this when I realised this would be a good career for me, so I made sure I got some before I finished my PhD.

What skills did you need to transfer?

Science communication was the main one. Lots of the work I did in terms of translating complex science and articulating it in a readily understandable and translatable way was useful. It’s all about taking complex science from experts and translating that to something anyone can readily read and use to make a key decision based on that. Continue reading

Q&A with Gerjon Ikink: Using policy to change science

Gerjon Ikink

{credit}Courtesy of Gerjon Ikink{/credit}

Gerjon Ikink is currently in his fifth and final year of a PhD at the Netherlands Cancer Institute in Amsterdam, but is thinking about leaving research. He always wanted to be a scientist so that he could contribute to society by exploring the unknown in search of the truth, in this case research into the genetic pathways involved in breast cancer.

But a few years into his PhD, he found it difficult to imagine continuing down this career path. Although his interest in science hadn’t wavered, his feelings towards the infrastructure of the academic life had. Now he is planning on moving into the world of science and education policy, hoping to right the wrongs that are pulling him out of academia.

When did you become disillusioned by science?

When I was an undergraduate, science was all about looking for the answers to the big questions, looking for the truth and understanding how our world works. But during my PhD, and maybe a little before, I became disillusioned with this idea. Continue reading